Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $2.971B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KYMR | KYMERA THERAPEUTICS INC | 5,502,710 | $428M | 14.4% | — | — | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 3,356,782 | $267M | 9.0% | — | — | COM | 76155X100 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 19,751,284 | $260M | 8.8% | — | — | CLASS A ORD | 61559X104 |
| GPCR | STRUCTURE THERAPEUTICS INC | 3,479,022 | $242M | 8.1% | — | — | SPONSORED ADS | 86366E106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,295,893 | $132M | 4.5% | — | — | COM | 68062P106 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,495,290 | $118M | 4.0% | — | — | COM | 604749101 |
| GHRS | GH RESEARCH PLC | 8,827,712 | $112M | 3.8% | — | — | ORDINARY SHARES | G3855L106 |
| XNCR | XENCOR INC | 7,133,720 | $109M | 3.7% | — | — | COM | 98401F105 |
| ZYME | ZYMEWORKS INC | 3,938,641 | $104M | 3.5% | — | — | COM | 98985Y108 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 879,009 | $92.01M | 3.1% | — | — | COM | 697947109 |
| KURA | KURA ONCOLOGY INC | 8,617,162 | $89.53M | 3.0% | — | — | COM | 50127T109 |
| STOK | STOKE THERAPEUTICS INC | 2,265,674 | $71.91M | 2.4% | — | — | COM | 86150R107 |
| XOMA | XOMA ROYALTY CORPORATION | 2,590,303 | $68.88M | 2.3% | — | — | COM NEW | 98419J206 |
| ABVX | ABIVAX SA | 508,031 | $68.51M | 2.3% | — | — | SPONSORED ADS | 00370M103 |
| NKTR | NEKTAR THERAPEUTICS | 1,559,595 | $65.94M | 2.2% | — | — | COM NEW | 640268306 |
| ACIU | AC IMMUNE SA | 19,822,436 | $62.24M | 2.1% | — | — | SHS | H00263105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,835,886 | $60.15M | 2.0% | — | — | COM | 61225M102 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $59.52M | 2.0% | — | — | COM | 230031106 |
| TYRA | TYRA BIOSCIENCES INC | 2,127,665 | $55.94M | 1.9% | — | — | COM | 90240B106 |
| IRON | DISC MEDICINE INC | 650,000 | $51.62M | 1.7% | — | — | COM | 254604101 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,488,975 | $50.29M | 1.7% | — | — | ADS | 45258D105 |
| IVVD | INVIVYD INC | 19,525,000 | $48.23M | 1.6% | — | — | COM | 00534A102 |
| SEPN | SEPTERNA INC | 1,720,782 | $47.98M | 1.6% | — | — | COM | 81734D104 |
| ANNX | ANNEXON INC | 9,128,080 | $45.82M | 1.5% | — | — | COM | 03589W102 |
| CMPX | COMPASS THERAPEUTICS INC | 7,764,842 | $41.7M | 1.4% | — | — | COM | 20454B104 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,629,289 | $34.72M | 1.2% | — | — | COM | 35104E100 |
| CBIO | CRESCENT BIOPHARMA INC. | 2,748,763 | $32.6M | 1.1% | — | — | COM | G2545C104 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $28.63M | 1.0% | — | — | COM | 344174107 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $26.87M | 0.9% | — | — | COM | 760273102 |
| AVTX | AVALO THERAPEUTICS INC | 1,355,257 | $24.61M | 0.8% | — | — | COM NEW | 05338F306 |
| PEPG | PEPGEN INC | 1,915,000 | $12.47M | 0.4% | — | — | COM | 713317105 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $9.503M | 0.3% | — | — | COM | 28617K101 |
| XFOR | X4 PHARMACEUTICALS INC | 2,233,742 | $8.935M | 0.3% | — | — | COM NEW | 98420X202 |
| AXSM | AXSOME THERAPEUTICS INC | 45,757 | $8.357M | 0.3% | — | — | COM | 05464T104 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $5.822M | 0.2% | — | — | ADS | 60853G106 |
| IMA | IMAGENEBIO INC | 802,102 | $5.535M | 0.2% | — | — | COM | 45175G207 |
| TCRX | TSCAN THERAPEUTICS INC | 5,226,074 | $5.226M | 0.2% | — | — | COM | 89854M101 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $4.139M | 0.1% | — | — | COM NEW | 88032L605 |
| IMUX | IMMUNIC INC | 7,652,972 | $4.084M | 0.1% | — | — | COM | 4525EP101 |
| IVA | INVENTIVA SA | 686,040 | $3.19M | 0.1% | — | — | ADS | 46124U107 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $2.401M | 0.1% | — | — | *W EXP 10/31/202 | 29286M113 |